From Bioblast
Revision as of 11:34, 23 November 2017 by Beno Marija (talk | contribs) (Created page with "{{OROBOROS header page name}} {{Publication |title=200px|right '''Hinxton, Cambridge UK''', 2018 May 09-11. Mitochondrial Medicine conference |info...")
Mitochondrial Medicine 2018 Hinxton UK
Hinxton, Cambridge UK, 2018 May 09-11. Mitochondrial Medicine conference |
Wellcome Genome Campus (2018-05-09) MitoGlobal
Abstract: Mitochondrial Medicine conference. Hinxton, United Kingdom; 2018.
General information
- The year’s meeting aims to bridge the gap between our current understanding of the mechanisms and processes that go awry in mitochondrial disease and the novel approaches being developed to treat them. We will also include sessions on clinical trial design and cohorts that are trial ready. In addition, there will be a late-breaking session focusing on new clinical intervention studies.
- This conference will bring together leaders in the field of translational mitochondrial medicine, with a programme designed to engage and inspire the next generation of mitochondrial researchers. The meeting attracts international participants interested in mitochondrial diseases, working in molecular genetics, biochemistry, pathology, and clinical medicine
Venue
- Wellcome Genome Campus Conference Centre
- Hinxton, Cambridge
- CB10 1SA, UK
- Location
Organizers
- Scientific programme committee:
- Patrick Chinnery University of Cambridge, UK
- Marni Falk The Children’s Hospital of Philadelphia, USA
- Vamsi Mootha Harvard Medical School, USA
- Jan Smeitink Radboud UMC, The Netherlands
- Anu Suomalainen University of Helsinki, Finland
- Massimo Zeviani MRC Mitochondrial Biology Unit, Cambridge, UK
- Scientific programme committee:
- Conference organiser
- Lucy Criddle Wellcome Genome Campus, UK
- Conference organiser
Programme
- Topics will include:
- Precision diagnostics and new clinical biomarkers
- What determines the phenotype of mitochondrial diseases?
- Autophagy-mitophagy: is it important for mitochondrial disease?
- Fission/fusion defects in mitochondrial disease: cause or effect?
- Mitochondrial biogenesis: the key to therapy?
- Gene editing to treat mitochondrial diseases
- Clinical trials
- Late breaking clinical intervention studies
- Translating microbiome science to impact global populations
- Topics will include:
- A draft programme is available here.
Registration
Lecturers and tutors
- The list of speakers can be seen here
Labels:
ORO, 2018, MitoGlobal, Next
Listed under MitoGlobal Events